14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
Germany’s cabinet has approved draft legislation designed to tighten the country’s foreign investm...
Read More >
States, counties and municipalities have issued “stay at home,” “shelter-in-place,” and other or...
Read More >
On August 12, 2019, New York State (NYS) amended its Human Rights Law to make it easier to prove dis...
Read More >
On June 13, 2019, the New York City Council passed Intro 799 to prohibit retaliation against individ...
Read More >
Even the best compliance initiative can’t survive a bad rollout. That’s why it’s essential that ...
Read More >
As expected, California’s effort to ban employers from requiring employees and applicants to sign a...
Read More >